Waverley Pharma Inc. WAVE.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.93% | 14.77% | 18.11% | -759.70% | 19.92% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.47% | 1.42% | -60.15% | 515.63% | -455.56% |
| Change in Net Operating Assets | -77.72% | 153.80% | -1,853.85% | 112.46% | 70.44% |
| Cash from Operations | -24.84% | 72.67% | -72.42% | -104.05% | 56.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -31.71% | -57.97% | 240.15% | -15.73% | 146.46% |
| Total Debt Repaid | 2.38% | -7.69% | 4.88% | 0.00% | 4.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -35.05% | -59.62% | 269.77% | -17.31% | 213.25% |
| Foreign Exchange rate Adjustments | 0.00% | 133.33% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.84% | 205.52% | 71.80% | -2,323.08% | 104.04% |